期刊文献+

帕利哌酮与利培酮对首发男性精神分裂症患者糖脂代谢影响的对照研究 被引量:12

A Comparative Study of the Effects of Paliperidone and Risperidone on the Glucose and Lipid Metabolism in First-Episode Male Schizophrenia Patients
原文传递
导出
摘要 目的比较帕利哌酮与利培酮对首发男性精神分裂症患者血糖和血脂代谢的影响。方法 80例首发男性精神分裂症患者随机分为帕利哌酮组(n=40)和利培酮组(n=40),分别给以帕利哌酮缓释片和利培酮片口服,检测入组时和治疗4、8周后两组空腹血糖、胰岛素、C肽、胆固醇、甘油三酯,测定身高、体质量,计算出体质指数,及评定入组时和治疗2、4、8周后两组的PANSS分值。结果帕利哌酮与利培酮的疗效比较差异无统计学意义(P>0.05)。治疗8周后,利培酮组患者的体质指数、胰岛素、C肽、胆固醇、甘油三酯升高,而帕利哌酮则改变不显著。两组治疗前后的空腹血糖值比较,差异无统计学意义。结论帕利哌酮对首发男性精神分裂症血糖、血脂的影响小于利培酮。 OBJECTIVE To compare the effects of paliperidone and risperidone on the glucose and lipid metabolism in first-episode male schizophrenia patients. METHODS Eighty first-episode male schizophrenics were randomly divided into paliperidone group ( n = 40) and risperidone group ( n = 40). They were treated with paliperidone ER and risperidone respectively. Before and 4 and 8 weeks after the treatment, the height, bodyweight, fasting blood glucose, fasting insulin, C-peptide, cholesterol and triglyceride were measured. In addition, the body mass index were calculated, and the antipsychotic efficacy was evaluated using positive and negative symptom syndrome scale (PANSS) before and 2, 4, and 8 weeks after the treatment. RESULTS After 8 weeks treatment, paliperidone was as effec- tive as risperidone(P 〉 0. 05 ). The fasting insulin, C- peptide, cholesterol, triglyceride and the body mass index in risperidone group were higher than those before treatment. But in paliperidone group, there was no difference before and after treatment. CONCLUSION Paliperidone has fewer effects on the glucose and lipid metabolism in first-episode male schizophrenia patients than risperidone.
出处 《中国药学杂志》 CAS CSCD 北大核心 2013年第8期649-651,共3页 Chinese Pharmaceutical Journal
关键词 帕利哌酮 利培酮 精神分裂症 糖脂代谢 paliperidone risperidone schizophrenia glucolipid metabolism
  • 相关文献

参考文献2

二级参考文献31

  • 1喻东山,余琳.精神药物和高催乳素血症[J].中国新药与临床杂志,2004,23(12):893-896. 被引量:44
  • 2FOWLER JA, BETTINGER TL, ARGO TR. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia[ J ]. Clin Ther, 2008,30 ( 2 ) :231 - 248.
  • 3American Psychiation Association Diagnositc and statistical manual of mental disorders [ M]. 4th ed. DSM-IV. Washington:APA, 1994 ; 273 - 292.
  • 4MARDER SR, KRAMERM,FORD L, et al. Efficacy and safety of paliperidone exte-nded-release tablets: Results of a 6-week, randomized, placebo controlled study [ J 1. Biol Psychiatry, 2007,62(12) :1363 - 1370.
  • 5KANE J, CANAS F, KRAMER M, et al. Treatment of schizophrenia with paliperidone extended release tablets: A 6-week placebo-controlled trial[ J]. Schizophr Res, 2007,90 (12) :147 - 161.
  • 6DAV IDSON M, EMSLEY R, KRAMERM, et al. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER) : Results of a 6-week randomized, placebocontrolled study [ J ]. Schizophr Res, 2007,93 ( 123 ) : 117 - 130.
  • 7CANUSO CM, YOUSSEF EA, BOSSIE CA, et al. Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone[ J ]. Int Clin Psychopharrn acol, 2008, 23 (4) :209 -215.
  • 8KNEQTERING R, BASELMANS P, CASTELEIN S,et al. Predominant role of the 9-hydroxymetabolite of risperidone in eleva- ting blood prolactin levels [ J]. Am J Psychiatry, 2005, 162 (5) : 1010 - 1012.
  • 9BOWDEN CR, VIONA SJ, WOESTENBORGHSR,et al. Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro [ J ]. J Pharmacol Exp Ther, 1992, 262 ( 2 ) : 699 - 706.
  • 10DUVAL F, GUILLON MS, MOKRANJ MC,et al. Relationship between prolactin secretion, and plasma risperidone and 9- hydroxyrisperidone concentrations in adolescents with schizophreniform disorder [ J ]. Psychoneuroendocrinology, 2008, 33 (2) :255 -259.

共引文献37

同被引文献91

  • 1朱紫青,张明园.第3代抗精神病药阿立哌唑研究进展[J].中国医院用药评价与分析,2005,5(2):121-123. 被引量:116
  • 2范肖冬 汪向东 于欣 译.ICD-10精神与行为障碍分类[M].北京:人民卫生出版社,1993.197.
  • 3中华医学会精神病学分会.中国精神障碍分类与诊断标准[M].第3版,济南:山东科技出版社,2001:75-77.
  • 4Fowler JA. Bettinger TL, Argo TR. Paliperidone extended- release tablets for the acute and maintenance treatment of schizophrenia [ J ]. Clin ther, 2008, 30 (2) :231 - 248.
  • 5Davidson Mo Eesley R, Kramer M, et al. Efficacy, safety and early response of Paliperidone extended-release tablets ( Paliperidone ER ) : Results of a 6-week randomized, placebo controlled study[J]. Schizopr Res, 2007, 93 (1 - 3) :117 - 130.
  • 6Vermeir M, Narssens I, Remmerie B, et al. Absorption, Metabolism, and exertion of Paliperidone, a new monoamincrgic antagonist, in humans [ J ]. Dmg Metab Dispos, 2008, 36 (4) :769 - 779.
  • 7Sugai T,Suzuki Y,Fukui N,et al.Dysregulation of adipocytokines related to second-generation antipsychotics in normal fasting glucose patients with schizophrenia[J].Journal of Clinical Psychopharmacology,2012,32(3):390.
  • 8Venkatasubramanian G,Arasappa R,Christopher R,et al.Neuropharmacology of schizophrenia:is there a role for leptin[J].Clinical Chemistry and Laboratory Medicine,2010,48(6):895.
  • 9Grimaldi-Bensouda L,Rouillon F,Astruc B,et al.Does longacting injectable risperidone make a difference to the real-life treatment of schizophrenia?Results of the Cohort for the General study of Schizophrenia(CGS)[J].Schizophrenia Research,2012,134(2/3):187.
  • 10Grootens KP,Van Veelen NM,Peuskens J,et al.Ziprasidone vs Olanzapine in recent-onset schizophrenia and schizoaffective disorder:results of an 8-week double-blind randomized controlled trial[J].Schizophr Bull,2011,37(2):352-361.

引证文献12

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部